|
|
|
40
|
05415
|
BLEOMYCIN SULPHATE 15MG INJ (CIP/AHI)
|
BLEOMYCIN SULPHATE
|
BLEOMYCIN SULPHATE
|
15MG VIAL
|
BQ
|
44.85
|
44.85
|
INJECTION
|
0
|
VIAL
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0884AJ
|
ASTHALIN 5MG/ML RESP SOL (CIP/AHI) SALBUTAMOL
|
SALBUTAMOL
|
ASTHALIN
|
15ML
|
A
|
2.91
|
2.91
|
RESPIRATORY
|
20
|
BOTT
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
48120412
|
SELECTIVE BETA2 ADRENERGIC AGONIST (RESPIRATORY)
|
2022-04-01
|
2024-03-31
|
|
INHALATION
|
6
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
41
|
0884AJ
|
ASTHALIN 5MG/ML RESP SOL (CIP) SALBUTAMOL
|
SALBUTAMOL
|
ASTHALIN
|
15ML
|
A
|
1.96
|
1.9572
|
BOTT
|
20
|
BOTT
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
48120412
|
SELECTIVE BETA2 ADRENERGIC AGONIST (RESPIRATORY)
|
2024-04-01
|
2026-03-31
|
|
INHALATION
|
6
|
SELECTIVE BETA2 ADRENERGIC AGONIST (RESPIRA
|
|
|
|
|
42
|
0884AJ
|
ASTHALIN 5MG/ML RESP SOL (CIP) SALBUTAMOL
|
SALBUTAMOL
|
ASTHALIN
|
15ML
|
A
|
2.07
|
2.07
|
BOTT
|
20
|
BOTT
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
48120412
|
SELECTIVE BETA2 ADRENERGIC AGONIST (RESPIRATORY)
|
2026-04-01
|
|
|
INHALATION
|
6
|
SELECTIVE BETA2 ADRENERGIC AGONIST (RESPIRA
|
|
|
|
|
40
|
0884BL
|
IPRAVENT 0.25MG/ML RESP SOL (CIP/AHI) IPRATRO
|
IPRATROPIUM BROMIDE
|
IPRAVENT
|
20X2ML
|
A
|
32.70
|
1.64
|
RESPIRATORY
|
1
|
AMP
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
481208
|
ANTICHOLINERGIC AGENTS (RESPIRATORY)
|
2022-04-01
|
2024-03-31
|
|
Nasal
|
6
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
40
|
0884BT
|
IPRAVENT 0.25MG/ML RESP SOL (CIP/AHI) IPRATRO
|
IPRATROPIUM BROMIDE
|
IPRAVENT
|
15ML
|
A
|
1.82
|
1.82
|
RESPIRATORY
|
1
|
BOTT
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
481208
|
ANTICHOLINERGIC AGENTS (RESPIRATORY)
|
2022-04-01
|
2024-03-31
|
|
Nasal
|
6
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
41
|
0884BT
|
IPRAVENT 0.25MG/ML RESP SOL (CIP) IPRATROPIUM
|
IPRATROPIUM
|
IPRAVENT
|
15ML
|
A
|
6.5
|
6.4968
|
BOTT
|
1
|
BOTT
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
481208
|
ANTICHOLINERGIC AGENTS (RESPIRATORY)
|
2024-04-01
|
2026-03-31
|
|
NASAL
|
6
|
ANTICHOLINERGIC AGENTS (RESPIRATORY)
|
|
|
|
|
42
|
09122
|
IPRAVENT 0.25MG/ML RESP SOL (CIP) IPRATROPIUM
|
IPRATROPIUM
|
IPRAVENT
|
15ML
|
A
|
3.23
|
3.23
|
BOTT
|
1
|
BOTT
|
CIP
|
CIPLA LTD
|
|
ARMSTRONG HEALTHCARE INC
|
B
|
481208
|
ANTICHOLINERGIC AGENTS (RESPIRATORY)
|
2026-04-01
|
|
|
ORAL INHALATION
|
6
|
ANTICHOLINERGIC AGENTS (RESPIRATORY)
|
|
|
|
|
41
|
1131FZ
|
XTOR 10MG TAB (IPC) ATORVASTATIN
|
ATORVASTATIN
|
XTOR
|
100'S
|
A
|
3.97
|
0.0397
|
TAB
|
30
|
BOX
|
IPC
|
IPCA Laboratories Ltd.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
41
|
1132HM
|
XTOR 20MG TAB (IPC) ATORVASTATIN
|
ATORVASTATIN
|
XTOR
|
100'S
|
A
|
4.68
|
0.0468
|
TAB
|
30
|
BOX
|
IPC
|
IPCA Laboratories Ltd.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
40
|
11529
|
GEMFIBROZIL 600MG TAB (CIP/AHI)
|
GEMFIBROZIL
|
GEMFIBROZIL
|
60'S
|
B
|
40.86
|
0.68
|
TABLET
|
60
|
TAB
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240606
|
FIBRIC ACID DERIVATIVES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
11529
|
GEMFIBROZIL 600MG TAB (CIP)
|
GEMFIBROZIL
|
GEMFIBROZIL
|
60'S
|
B
|
40.86
|
0.6809
|
TAB
|
60
|
BOX
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240606
|
FIBRIC ACID DERIVATIVES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
FIBRIC ACID DERIVATIVES
|
|
|
|
|
42
|
11529
|
GEMFIBROZIL 600MG TAB (CIP)
|
GEMFIBROZIL
|
GEMFIBROZIL
|
60'S
|
C
|
40.91
|
0.68
|
TAB
|
60
|
BLIS
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240606
|
FIBRIC ACID DERIVATIVES
|
2026-04-01
|
|
|
ORAL
|
6
|
FIBRIC ACID DERIVATIVES
|
|
|
|
|
42
|
1181FX
|
BISOPROLOL 2.5MG TAB (IPC)
|
BISOPROLOL
|
BISOPROLOL
|
28'S
|
A
|
1.03
|
0.04
|
TAB
|
30
|
BLIS
|
IPC
|
IPCA Laboratories Ltd.
|
CWS
|
CAPSULE WHOLESALE
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2026-04-01
|
|
|
ORAL
|
6
|
BETA ADRENERGIC BLOCKING AGENTS
|
|
|
|
|
42
|
1182FP
|
BISOPROLOL 5MG TAB (IPC)
|
BISOPROLOL
|
BISOPROLOL
|
28'S
|
A
|
1.03
|
0.04
|
TAB
|
30
|
BLIS
|
IPC
|
IPCA Laboratories Ltd.
|
CWS
|
CAPSULE WHOLESALE
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2026-04-01
|
|
|
ORAL
|
6
|
BETA ADRENERGIC BLOCKING AGENTS
|
|
|
|
|
40
|
1183G
|
METOPROLOL 1MG/ML INJ (CIP/AHI)
|
METOPROLOL
|
METOPROLOL
|
5X5ML
|
BQ
|
13.21
|
2.64
|
INJECTION
|
0
|
VIAL
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
1183G
|
METOLAR 1MG/ML INJ (CIP) METOPROLOL
|
METOPROLOL
|
METOLAR
|
5X5ML
|
BQ
|
13.21
|
2.6422
|
VIAL
|
0
|
BOX
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
BETA ADRENERGIC BLOCKING AGENTS
|
|
|
|
|
42
|
1184AA
|
BISOPROLOL 10MG TAB (IPC)
|
BISOPROLOL
|
BISOPROLOL
|
28'S
|
A
|
1.60
|
0.06
|
TAB
|
30
|
BLIS
|
IPC
|
IPCA Laboratories Ltd.
|
CWS
|
CAPSULE WHOLESALE
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2026-04-01
|
|
|
ORAL
|
6
|
BETA ADRENERGIC BLOCKING AGENTS
|
|
|
|
|
41
|
1421BF
|
PACIMOL 500MG TAB (IPC) PARACETAMOL
|
PARACETAMOL
|
PACIMOL
|
100'S
|
A
|
3.51
|
0.0351
|
TAB
|
180
|
BOX
|
IPC
|
IPCA Laboratories Ltd.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
280892
|
ANALGESICS AND PYRETICS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANALGESICS AND PYRETICS MISCELLANEOUS
|
|
|
|
|
42
|
1652B
|
HYDROXYZINE 10MG TAB (IPC)
|
HYDROXYZINE
|
HYDROXYZINE
|
84'S
|
A
|
10.93
|
0.13
|
TAB
|
90
|
BLIS
|
IPC
|
IPCA Laboratories Ltd.
|
CWS
|
CAPSULE WHOLESALE
|
|
282492
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCELLANEOUS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANXIOLYTICS, SEDATIVES AND HYPNOTICS MISCEL
|
|
